bosentan anhydrous has been researched along with Sjogren's Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Konishi, K; Kuriyama, T; Maruoka, M; Nakamura, M; Shigeta, A; Shinohara, M; Tada, Y; Takiguchi, Y; Tanabe, N; Tatsumi, K; Toyama, S; Yasuda, T | 1 |
Guillevin, L | 1 |
1 review(s) available for bosentan anhydrous and Sjogren's Syndrome
Article | Year |
---|---|
Vasculopathy and pulmonary arterial hypertension.
Topics: Antihypertensive Agents; Bosentan; Churg-Strauss Syndrome; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Scleroderma, Systemic; Sjogren's Syndrome; Sulfonamides; Vasculitis | 2009 |
1 other study(ies) available for bosentan anhydrous and Sjogren's Syndrome
Article | Year |
---|---|
[Pulmonary hypertension in a patient on chronic hemodialysis].
Topics: Antihypertensive Agents; Bosentan; Female; Humans; Hypertension, Pulmonary; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Sjogren's Syndrome; Sulfonamides | 2009 |